Apotex Health Corp (APTX : TSX)
Common Stock
$35.95
CAD
-0.60 (-1.64%)
Last updated: 2026-07-23
Get APTX alerts:
APTX
Apotex Health Corp
WealthAwesomePerformance
1 Day
-1.64%
1 Week
-3.75%
1 Month
+17.64%
YTD
+30.73%
Key Statistics
Market Cap
$8.33B
52W High
$40.18
52W Low
$26.05
P/E Ratio
21.92
50 Day MA
$33.54
200 Day MA
$33.54
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/23/2026 | $36.65 | $37.18 | $35.42 | $35.95 | $35.95 | 493,693 |
| 7/22/2026 | $38.00 | $38.00 | $34.33 | $36.55 | $36.55 | 1,650,844 |
| 7/21/2026 | $37.77 | $39.98 | $37.50 | $39.67 | $39.67 | 466,812 |
| 7/20/2026 | $38.05 | $38.47 | $37.48 | $37.54 | $37.54 | 298,780 |
| 7/17/2026 | $37.21 | $38.19 | $37.07 | $37.68 | $37.68 | 204,225 |
| 7/16/2026 | $40.18 | $40.18 | $37.11 | $37.35 | $37.35 | 396,071 |
| 7/15/2026 | $37.86 | $40.16 | $37.77 | $39.64 | $39.64 | 310,346 |
| 7/14/2026 | $37.96 | $38.20 | $37.38 | $38.00 | $38.00 | 185,885 |
| 7/13/2026 | $37.95 | $39.50 | $37.31 | $37.70 | $37.70 | 272,330 |
| 7/10/2026 | $37.90 | $38.69 | $36.99 | $38.00 | $38.00 | 330,453 |
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 13.2% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$40.69
+13.2% Upside
Current Price
C$35.95
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
About Apotex Health Corp
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
Financials
- Revenue (TTM)
- $3.49B
- EBITDA
- $1.19B
- Profit Margin
- 10.71%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- 1.64
- Book Value
- -2.89
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About APTX
Articles Featuring APTX.TO
Latest articles and analysis covering APTX.TO
Why Apotex Health Corp stock plummeted yesterday
Apotex Health Corp's stock plummeted by 7.86% yesterday, closing at CA$36.55, raising concerns among investors about the company's stability and future performance.
Apotex Health Corp. (APTX.TO) Faces 7% Decline This Week Amid Mixed News
Apotex Health Corp. has seen a 7% decline this week, raising questions about its growth prospects despite recent positive news.
Why Apotex Health Corp stock is plummeting today
Apotex Health Corp is experiencing a troubling 7.78% decline in its stock price today, raising questions about its market position despite recent strategic moves.
What's Going On With Apotex Health Corp Stock Monday?
Apotex Health Corp (APTX.TO) is experiencing a mix of upward and downward movements in its stock price amidst significant corporate developments. The recent investment-grade rating and strategic acquisitions may provide a strong foundation for future growth.
Why Apotex Health Corp stock is gaining today
Apotex Health Corp's stock is gaining traction, closing at CA$37.96 with a 1.63% increase, driven by strategic financial maneuvers and a favorable market environment.
Apotex Health Corp. (APTX.TO) Surges 15% Over the Last Month — What’s Driving the Momentum?
Apotex Health Corp. (APTX.TO) has gained 15% in the last month, driven by its new listing on the TSX and strong market positioning in the pharmaceutical sector.
What's Going On With Apotex Health Corp Stock Monday?
Apotex Health Corp's stock has seen a significant weekly increase, reflecting positive market sentiment and strategic corporate actions. As the company integrates new business segments and receives regulatory approvals, investors are watching closely for future developments.
Why Apotex Health Corp stock is gaining today
Apotex Health Corp's shares have gained 1.80% today, closing at CA$38.37, bolstered by recent strategic developments in the pharmaceutical sector.
Why Apotex Health Corp stock is skyrocketing today
Apotex Health Corp's stock soared by 7.22% today, driven by positive market sentiment and recent strategic developments. Investors are optimistic about the company's future prospects.
Why Apotex Health Corp stock is skyrocketing today
Apotex Health Corp's stock soared by 6.15% today, driven by strategic developments and new product approvals that signal a promising future for the company.
Apotex Health Corp. (APTX.TO) Gains 10% This Week — What’s Driving the Surge?
Apotex Health Corp. has surged 10% this week, driven by strategic growth initiatives and positive analyst sentiment. Here's what investors should know.
Why Apotex Health Corp stock is skyrocketing today
Apotex Health Corp's stock experienced a robust increase of 5.26% in the last trading session, driven by positive market sentiment and strategic advancements in its product offerings.
Why Apotex Health Corp stock is rising today
Apotex Health Corp's stock has experienced a 4.75% increase, reflecting positive investor sentiment amidst its strategic developments in the pharmaceutical sector.
Why Apotex Health Corp stock is sliding today
Apotex Health Corp's stock has taken a hit, dropping 3.84% in the last trading session, raising concerns about its future performance post-IPO.
Why Apotex Health Corp stock is skyrocketing today
Apotex Health Corp's stock soared by 8.35% today, closing at CA$33.61, driven by optimism following its recent IPO and product approvals.
Why Apotex Health Corp stock is rising today
Apotex Health Corp is experiencing a significant rise in its stock price, attributed to investor optimism surrounding its IPO and new product approvals.
Apotex Health Corp. (APTX.TO) Surges on IPO Buzz — What Investors Should Know
Apotex Health Corp. saw a significant rise in its stock price yesterday, driven by investor excitement over its upcoming IPO. With a market cap of CA$7.54 billion, the company is poised for growth.
Why Apotex Health Corp stock is rising today
Apotex Health Corp's stock rose by 3.89% in the last session, driven by positive investor sentiment and anticipation of its upcoming IPO and product launches.
Why Apotex Health Corp stock is gaining today
Apotex Health Corp's stock has gained 1.40% in the last session, closing at CA$29.75. This positive movement reflects growing investor confidence following the company's recent IPO activities.
Why Apotex Health Corp stock is rising today
Apotex Health Corp's stock has surged by 3.15% after celebrating its listing on the Toronto Stock Exchange, indicating strong investor confidence in the company's future.
Showing latest 20 articles